Dr. Steven T. Rosen, MD, FACP, FASCO, FAIMBE
Oncologist & Hematologist
City of Hope National Medical Centre,
Steven T. Rosen, MD, FACP, FASCO, is the provost, chief scientific officer, and director of the Comprehensive Cancer Center and the Beckman Research Institute, Irell & Manella Cancer Center Director’s Distinguished Chair for the City of Hope in Duarte, California. Following his graduation with distinction from Northwestern University Medical School’s Six-Year Honors Program in Chicago, Illinois, Dr Rosen completed his residency in internal medicine at Northwestern and a fellowship in medical oncology at the National Cancer Institute in Maryland. He served as the Director of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University Feinberg School of Medicine from 1989-2014.
Dr Rosen’s laboratory research focuses on experimental therapeutics and hematologic malignancies. He has received funding from the National Cancer Institute (NCI), American Cancer Society, Leukemia and Lymphoma Society (LLS), Multiple Myeloma Research Foundation, and Rising Tide Foundation. Dr Rosen has received numerous grant awards and contracts, and has published more than 400 scientific papers. He is editor-in-chief of Cancer Treatment and Research. Dr Rosen is the chair of the Medical Science Committee of the LLS and serves on its Board. He also serves on the Board of American Society of Clinical Oncology’s Conquer Cancer Foundation. Dr Rosen has been an advisor to more than two dozen NCI Comprehensive Cancer Centers.
He was the recipient of Northwestern University Medical School’s Alumni Achievement Award (1994), the Martin Luther King Humanitarian Award from Northwestern Memorial Hospital (1995), the Marv Samuel Award from the Chicago Baseball Cancer Charities (1996), recognition from the Woman’s Board of Northwestern Memorial Hospital for Compassionate Care (1996), and Israel Cancer Research Fund, Man of Distinction Award (2011), and Lifetime Achievement Award (2015). Best Doctors in Chicago and Los Angeles. American Institute for Medical and Biological Engineering (AIMBE’s) College of Fellows (2017). Association of American Physicians (AAP) (2019). The Giants of Cancer Care award for 2021.
Dr. Steve Daveluy, MD
Wayne State University, Detroit, Michigan
Dr. Daveluy is an associate professor and program director at Wayne State University in Detroit, Michigan. He earned a bachelor in science from Michigan State University. He completed medical school and his dermatology residency at Wayne State University.
He holds special interests in teledermatology, noninvasive skin imaging, skin of color, integrative dermatology, and complex medical dermatology, including hidradenitis suppurativa. He chairs the AAD Performance Measure Committee. He is the past president of the Wayne County Medical Society. He serves on the editorial board for the JAAD and is building a growing body of publications of his own. He is lives across the border in Windsor, Ontario, Canada with his husband and very spoiled dog.
Dr. Basem William, MD, MRCP(UK), FACP
Hematologist & Oncologist
Dr Basem William is a hematologist with an internationally-recognized expertise in hematological malignancies, lymphoma, T-cell lymphomas (cutaneous and systemic), drug development, hematopoietic stem cell transplantation and cellular therapy. He has been a PI/co-investigator/site PI on over 100 clinical trials in hematological malignancies and cell therapy. He published over 70 peer reviewed articles, over 100 peer-reviewed abstracts, and 4 books chapters and has previously served on the NCCN Guidelines expert panel in T-cell Lymphomas. He is certified by the American Board of Internal Medicine in Hematology, Oncology, Internal Medicine, and Hospice/Palliative Medicine and is a member of the Royal College of Physicians of the United Kingdom. After leading the T-cell lymphoma program at the Ohio State University Comprehensive Cancer Center, where he was an Associate Professor of Internal Medicine, for the past 4 years, he recently joined OhioHealth Health system to help build a new comprehensive hematological malignancies, transplant, and cell therapy program.
Dr. Jina Chung
Assistant Professor in Dermatology and Dermatopathology
Oregon Health and Science University, Portland, Oregon
Dr. Jina Chung is a board-certified dermatologist and dermatopathologist, and she is the director of the Cutaneous Lymphoma Clinic at Oregon Health & Science University in Portland, Oregon. She sees patients with both T-cell and B-cell lymphoproliferative disorders, in the dermatology clinic as well as in a multi-disciplinary clinic with oncology. Dr. Chung obtained her medical degree from Johns Hopkins University School of Medicine in Baltimore, MD, followed by dermatology residency training at University of Iowa, and dermatopathology fellowship at Thomas Jefferson University in Philadelphia, PA. She regularly participates in the teaching of residents and medical students in both dermatology and dermatopathology at OHSU.
Dr. Jaehyuk Choi
Associate Professor Department of Dermatology and Department of Biochemistry and Molecular Genetics
Northwestern University - The Feinberg School of Medicine,
Dr. Jaehyuk Choi went to college at Harvard University (where he graduated summa cum laude with a degree in Biochemistry). He then went to Yale School of Medicine where he pursued a dual degree MD and a PhD in Immunobiology (where he graduated with Alpha Omega Alpha (AOA) honors, cum laude honors, and the award for the top thesis in his MD PhD class. Afterwards, he pursued clinical training in dermatology at Yale and postdoctoral training in cancer genetics. He then joined the faculty at Northwestern in Chicago where he is the associate professor of Dermatology and of Biochemistry and Molecular Genetics, the medical director of the extracorporeal photopheresis unit, the director of precision immunotherapy for the Lurie Cancer Center. He has revolutionized our understanding of the cellular and genetic origins of cutaneous lymphomas. He has published more than 50 manuscripts in high impact journals and been acknowledged with multiple honors including the NIH New Innovator Award as well as awards from the Damon Runyon Foundation, the Leukemia Lymphoma Society, and the American Society for Clinical Investigation. He and his group are proud of their scientific discoveries that have led to the identification of new clinical biomarkers and two clinical trials. His goal in the laboratory and in the clinic is to improve the ways in which we treat patients with skin lymphomas.
Dr. Trisha Scharff
Washington University School of Medicine,
St. Louis, Missouri
Dr. Trisha Scharff was born in St. Louis, Missouri and is a graduate of Northwestern University. She obtained her medical degree from Washington University School of Medicine in St. Louis. During her time at Washington University she also obtained her Master of Population Health Sciences (MPHS) degree with a focus on applied clinical research. Her research has centered on quality of life in cutaneous T-cell lymphoma, the use of immunotherapy in metastatic melanoma, and the treatment of skin cancer precursors to reduce the risk of cutaneous squamous cell carcinoma. She presented 3 international podium presentations on her work at the World Congress of Cutaneous Lymphomas in Barcelona in February 2020. As a senior medical student, she was awarded the Yalem award for outstanding work in dermatology, awarded annually to the top medical student in dermatology. She also received the Robert Carter Award, awarded annually for outstanding research contributions. She completed a transitional year including training in intensive care, internal medicine, and surgical subspecialties at Mercy Hospital in St. Louis and will complete her dermatology residency at Washington University School of Medicine in St. Louis. She currently resides in St. Louis, MO with her husband and her mini poodle Kulfi.
Dr. Niloufer Khan, MD, MS
Assistant Attending Physician
Memorial Sloan Kettering Cancer Center, New York City
Niloufer Khan, MD, MS is an Assistant Attending Physician on the Lymphoma Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center in New York City. She earned her medical degree at Case Western Reserve University School of Medicine, completed an internship and residency in Internal Medicine/Pediatrics at the University of Chicago, and then completed a fellowship in Hematology and Medical Oncology at Memorial Sloan Kettering Cancer Center, where she served as Chief Fellow.
Much of her current research is dedicated to improving cancer care and outcomes for patients with CTCL and quality of life for people with lymphoma and survivors of lymphoma. She is also involved in clinical trials to find new and better ways to treat rare lymphomas, such as Hodgkin lymphoma, cutaneous (skin) lymphoma, and T-cell lymphoma.
Dr. Lauren Pinter-Brown
Division of Hematology/ Oncology
Department of Medicine, UCI School of Medicine, California
Dr. Lauren C. Pinter-Brown is a board-certified, fellowship-trained UCI hematologist-oncologist who specializes in the diagnosis and treatment of patients with lymphomas.
A nationally recognized expert, Pinter-Brown has a longstanding interest in malignant lymphoma, with a particular focus on T-cell and skin lymphomas.
A prolific clinical investigator, Pinter-Brown has made important contributions to several clinical trials that led to approval of new drugs for the treatment of T-cell lymphoma. Her research focus is on optimizing treatment options for patients with lymphoma, especially cutaneous and T-cell lymphomas. Her primary goal is to care for patients through diagnosis, treatment and beyond and to ensure that they are able "to live their best life."